FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:2246-2247 May 26, 2005 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Cooper, D. S. PubMed Citation

To the Editor: In his review of antithyroid drugs (March 3 issue),¹ Cooper does not mention the potential advantage of combined treatment with antithyroid drugs and thyroxine (referred to as the "block–replace regimen"). Even if such a regimen has not been demonstrated to be superior in terms of definitive cure, for many clinicians it is a simpler and faster way to achieve euthyroidism in most patients with Graves' disease than is treatment with methimazole alone. High doses of methimazole may be associated with more minor side effects, but in controlled studies the doses used ranged from 30 to 60 mg . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.